LATEST TRIALS

  • Melanoma
    Safety of UV1 vaccination in combination with ipilimumab in patients with unresectable or metastatic malignant melanoma
  • Solide Tumores
    An open-label, phase 2 study of neratinib in patients with solid tumors with somatic human epidermal growth factor receptor (EGFR, HER2, HER3) mutations or EGFR gene amplification
  • Solide Tumores
    Safety and tolerability of single and repeated doses of ODM-203: an opel-label, non-randomized, uncontrolled, dose escalation, multicentre, first-in-human study in subjects with advanced solid tumors

NORDIC COOPERATION

Norway Norway Sweden Finland Aarhus Herlev Copenhagen